Development of the vault particle as a platform technology.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  ACS Nano

• Publication date

  2013-02-26

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1021/nn3052082PMID 23267674
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vault nanoparticles engineered with the protein transduction domain, TAT48, enhances cellular uptake.

  2013cited by this paper
• An evaluation of the safety and feasibility of convection-enhanced delivery of carboplatin into the white matter as a potential treatment for high-grade glioma

  2012cited by this paper
• Vault Nanocapsules as Adjuvants Favor Cell-Mediated over Antibody-Mediated Immune Responses following Immunization of Mice

  2012cited by this paper
• A phase I trial of carboplatin administered by convection-enhanced delivery to patients with recurrent/progressive glioblastoma multiforme.

  2012cited by this paper
• Intracellular transduction and potential of Tat PTD and its analogs: from basic drug delivery mechanism to application

  2012cited by this paper
• Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model.

  2011cited by this paper
• Vaults engineered for hydrophobic drug delivery.

  2011cited by this paper
• Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study.

  2011cited by this paper
• Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth

  2011cited by this paper
• Considerations when submitting nanotherapeutics to FDA/CDER for regulatory review.

  2011cited by this paper
• Targeted vault nanoparticles engineered with an endosomolytic peptide deliver biomolecules to the cytoplasm.

  2011cited by this paper
• Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines.

  2011cited by this paper
• All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma

  2010cited by this paper
• Nanoparticulate drug delivery systems for cancer chemotherapy

  2010cited by this paper
• Immobilization of recombinant vault nanoparticles on solid substrates.

  2010cited by this paper
• Vaults are dynamically unconstrained cytoplasmic nanoparticles capable of half vault exchange.

  2010cited by this paper
• Targeting nanodisks via a single chain variable antibody--apolipoprotein chimera.

  2009cited by this paper
• All Trans Retinoic Acid Nanodisks Enhance Retinoic Acid Receptor-Mediated Apoptosis and Cell Cycle Arrest in Mantle Cell Lymphoma.

  2009cited by this paper
• The Structure of Rat Liver Vault at 3.5 Angstrom Resolution

  2009influential reference
• Utilization of a protein "shuttle" to load vault nanocapsules with gold probes and proteins.

  2009cited by this paper
• Structural stability of vault particles.

  2009cited by this paper
• Targeting vault nanoparticles to specific cell surface receptors.

  2009cited by this paper
• Vault nanoparticles containing an adenovirus-derived membrane lytic protein facilitate toxin and gene transfer.

  2009cited by this paper
• Dendrimers: a class of polymers in the nanotechnology for the delivery of active pharmaceuticals.

  2009cited by this paper
• A Vault Nanoparticle Vaccine Induces Protective Mucosal Immunity

  2009cited by this paper
• Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer

  2008cited by this paper
• Vaults and the major vault protein: Novel roles in signal pathway regulation and immunity

  2008cited by this paper
• Nanoparticles target distinct dendritic cell populations according to their size

  2008cited by this paper
• Reversible pH lability of cross-linked vault nanocapsules.

  2008cited by this paper
• Encapsulation of semiconducting polymers in vault protein cages.

  2008cited by this paper
• Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.

  2008cited by this paper
• Retinoic acid syndrome: a review

  2008cited by this paper
• Nanodisks: hydrophobic drug delivery vehicles

  2008cited by this paper
• In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells.

  2008cited by this paper
• Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model.

  2008cited by this paper
• Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.

  2007cited by this paper
• Draft Crystal Structure of the Vault Shell at 9-Å Resolution

  2007cited by this paper
• Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives

  2007cited by this paper
• Retinoic acid-induced lumbosacral neural tube defects: myeloschisis and hamartoma

  2007cited by this paper
• Vault nanocapsule dissociation into halves triggered at low pH.

  2007cited by this paper
• All-trans-retinoic acid nanodisks.

  2007cited by this paper
• Ductal access for prevention and therapy of mammary tumors.

  2006cited by this paper
• Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B Published, JLR Papers in Press, November 28, 2005.

  2006cited by this paper
• The vault exterior shell is a dynamic structure that allows incorporation of vault-associated proteins into its interior.

  2006cited by this paper
• Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma.

  2006cited by this paper
• Nanodisk-Associated Amphotericin B Clears Leishmania major Cutaneous Infection in Susceptible BALB/c Mice

  2006cited by this paper
• Cellular functions of vaults and their involvement in multidrug resistance.

  2006cited by this paper
• Vaccination with the Chlamydia trachomatis Major Outer Membrane Protein Can Elicit an Immune Response as Protective as That Resulting from Inoculation with Live Bacteria

  2005cited by this paper
• Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine

  2005cited by this paper
• Cutting Edge: All-trans Retinoic Acid Down-Regulates TLR2 Expression and Function1

  2005cited by this paper
• Adenovirus Protein VI Mediates Membrane Disruption following Capsid Disassembly

  2005influential reference
• Solution structure of a two-repeat fragment of major vault protein.

  2005cited by this paper
• Baculovirus as versatile vectors for protein expression in insect and mammalian cells

  2005cited by this paper
• Engineering of vault nanocapsules with enzymatic and fluorescent properties.

  2005cited by this paper
• Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.

  2004cited by this paper
• Retinoids: potential in cancer prevention and therapy

  2004cited by this paper
• Retinoic acid receptors and cancers.

  2004cited by this paper
• Retinoids in cancer chemoprevention.

  2004cited by this paper
• Vault Poly(ADP-Ribose) Polymerase Is Associated with Mammalian Telomerase and Is Dispensable for Telomerase Function and Vault Structure In Vivo

  2004cited by this paper
• Intratumoral Administration of Dendritic Cells Overexpressing CCL21 Generates Systemic Antitumor Responses and Confers Tumor Immunity

  2004cited by this paper
• Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP.

  2004cited by this paper
• Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors.

  2003cited by this paper
• The vault complex

  2003cited by this paper
• Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens.

  2003cited by this paper
• Self-Assembly of Discoidal Phospholipid Bilayer Nanoparticles with Membrane Scaffold Proteins

  2002cited by this paper
• DNA nanoparticles and development of DNA delivery vehicles for gene therapy.

  2002cited by this paper
• Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo.

  2002cited by this paper
• Nasal-Associated Lymphoid Tissue Is a Mucosal Inductive Site for Virus-Specific Humoral and Cellular Immune Responses1

  2002cited by this paper
• Vault ribonucleoprotein particles: sarcophagi, gondolas, or safety deposit boxes?

  2002cited by this paper
• Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics.

  2002cited by this paper
• Differential Induction of Mucosal and Systemic Antibody Responses in Women After Nasal, Rectal, or Vaginal Immunization: Influence of the Menstrual Cycle1

  2002cited by this paper
• Viral capsid mobility: A dynamic conduit for inactivation

  2001cited by this paper
• Assembly of Vault-like Particles in Insect Cells Expressing Only the Major Vault Protein*

  2001cited by this paper
• Nonviral Vectors in the New Millennium: Delivery Barriers in Gene Transfer

  2001cited by this paper
• The Telomerase/Vault-Associated Protein Tep1 Is Required for Vault RNA Stability and Its Association with the Vault Particle

  2001cited by this paper
• Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts.

  2000cited by this paper
• Telomerase-Associated Protein TEP1 Is Not Essential for Telomerase Activity or Telomere Length Maintenance In Vivo

  2000cited by this paper
• RNA location and modeling of a WD40 repeat domain within the vault.

  2000cited by this paper
• Secondary Lymphoid Tissue Chemokine Mediates T Cell-Dependent Antitumor Responses In Vivo1

  2000cited by this paper
• The Role of Chemokines in the Microenvironmental Control of T versus B Cell Arrest in Peyer's Patch High Endothelial Venules

  2000cited by this paper
• The 193-Kd Vault Protein, Vparp, Is a Novel Poly(Adp-Ribose) Polymerase

  1999cited by this paper
• Vaults and Telomerase Share a Common Subunit, TEP1*

  1999cited by this paper
• A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes.

  1998influential reference
• Evidence of Viral Capsid Dynamics Using Limited Proteolysis and Mass Spectrometry*

  1998cited by this paper
• Vaults Are Up-regulated in Multidrug-resistant Cancer Cell Lines*

  1998cited by this paper
• Secondary Lymphoid-tissue Chemokine Is a Functional Ligand for the CC Chemokine Receptor CCR7*

  1998cited by this paper
• The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7

  1998cited by this paper
• Characterization of the sea urchin major vault protein: a possible role for vault ribonucleoprotein particles in nucleocytoplasmic transport.

  1997cited by this paper
• Initial route of antigen administration alters the T-cell cytokine profile produced in response to the mouse pneumonitis biovar of Chlamydia trachomatis following genital infection

  1996cited by this paper
• Biochemical pathways of retinoid transport, metabolism, and signal transduction.

  1996cited by this paper
• Vaults are the answer, what is the question?

  1996cited by this paper
• Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice.

  1996cited by this paper
• Minimizing a binding domain from protein A.

  1996cited by this paper
• The Major Vault Protein (MVP100) Is Contained in Cholinergic Nerve Terminals of Electric Ray Electric Organ*

  1996cited by this paper
• Dictyostelium Vaults: Disruption of the Major Proteins Reveals Growth and Morphological Defects and Uncovers a New Associated Protein (*)

  1995cited by this paper
• Vault ribonucleoprotein particles from rat and bullfrog contain a related small RNA that is transcribed by RNA polymerase III.

  1993cited by this paper
• cDNA cloning and disruption of the major vault protein alpha gene (mvpA) in Dictyostelium discoideum.

  1993cited by this paper
• Vaults. III. Vault ribonucleoprotein particles open into flower-like structures with octagonal symmetry

  1991cited by this paper
• Unlocking vaults: organelles in search of a function.

  1991cited by this paper
• Vaults. II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes

  1990cited by this paper

• Practical and translational therapeutic elements for GBM therapy.

  2026cites this paper
• Engineering the Peptide Coassembly into 2D Architectures for Enhanced DNA Interactions.

  2026cites this paper
• A genetically encoded device for transcriptome storage in mammalian cells.

  2026cites this paper
• Peptide cages: bioinspired supramolecular architectures for next-generation applications.

  2026cites this paper
• Vault Particles in Cancer Progression, Multidrug Resistance, and Drug Delivery: Current Insights and Future Applications

  2025cites this paper
• A guide to the biogenesis and functions of endogenous small non-coding RNAs in animals

  2025cites this paper
• Cryo-EM structure of the vault from human brain reveals symmetry mismatch at its caps

  2025cites this paper
• Exomeres and supermeres: Current advances and perspectives

  2025cites this paper
• Structure, Dynamics and Functional Implications of the Eukaryotic Vault Complex.

  2024cites this paper
• Integrin-Targeting Strategies for Adenovirus Gene Therapy

  2024cites this paper
• Encapsulation of AAVs into protein vault nanoparticles as a novel solution to gene therapy’s neutralizing antibody problem

  2024cites this paper
• A Versatile Virus-Mimetic Engineering Approach for Concurrent Protein Nanocage Surface-Functionalization and Cargo Encapsulation.

  2024cites this paper
• Application of nanomedicines in tumor immunotherapy

  2024cites this paper
• Extracellular vesicles and nanoparticles at a glance.

  2024cites this paper
• Amyloid-β-targeting immunotherapies for Alzheimer's disease.

  2024cites this paper
• Extracellular vesicles and nanoparticles: emerging complexities.

  2023cites this paper
• Addressing Critical Issues Related to Storage and Stability of the Vault Nanoparticle Expressed and Purified from Komagataella phaffi

  2023cites this paper
• Tailored Functionalized Protein Nanocarriers for Cancer Therapy: Recent Developments and Prospects

  2023influential citation
• Engineering Self-Assembling Protein Nanoparticles for Therapeutic Delivery

  2022cites this paper
• Protein-based nanocages for vaccine development.

  2022cites this paper
• Escherichia coli as a New Platform for the Fast Production of Vault-like Nanoparticles: An Optimized Protocol

  2022cites this paper
• Decolorization and detoxification of synthetic dye compounds by laccase immobilized in vault nanoparticles.

  2022cites this paper
• The Vault Nanoparticle: A Gigantic Ribonucleoprotein Assembly Involved in Diverse Physiological and Pathological Phenomena and an Ideal Nanovector for Drug Delivery and Therapy

  2021cites this paper
• Heat-induced transitions of an empty minute virus of mice capsid in explicit water: all-atom MD simulation

  2021cites this paper
• Polyelectrolyte Encapsulation and Confinement within Protein Cage-Inspired Nanocompartments

  2021cites this paper
• Biomaterials, biological molecules, and polymers in developing vaccines.

  2021cites this paper
• Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies

  2021cites this paper
• Self-Assembling Nanovaccine Enhances Protective Efficacy Against CSFV in Pigs

  2021cites this paper
• Nanotechnological Applications Based on Bacterial Encapsulins

  2021cites this paper
• Bioscaffold-based study of glioblastoma cell behavior and drug delivery for tumor therapy.

  2021cites this paper
• Vault nanocapsule-mediated biomimetic silicification for efficient and robust immobilization of proteins in silica composites

  2021cites this paper
• Genetically Encodable Scaffolds for Optimizing Enzyme Function

  2021cites this paper
• Two-tier supramolecular encapsulation of small molecules in a protein cage

  2020cites this paper
• The biomedical and bioengineering potential of protein nanocompartments.

  2020cites this paper
• Chemical engineering of protein cages and nanoparticles for pharmaceutical applications

  2020cites this paper
• Harnessed viruses in the age of metagenomics and synthetic biology: an update on infectious clone assembly and biotechnologies of plant viruses

  2019cites this paper
• Structural nanotechnology: three-dimensional cryo-EM and its use in the development of nanoplatforms for in vitro catalysis.

  2019cites this paper
• Nanomaterial-Supported Enzymes for Water Purification and Monitoring in Point-of-Use Water Supply Systems.

  2019cites this paper
• Reassessment of Exosome Composition.

  2019cites this paper
• A Vault-Encapsulated Enzyme Approach for Efficient Degradation and Detoxification of Bisphenol A and Its Analogues.

  2019cites this paper
• High-symmetry protein assemblies: patterns and emerging applications.

  2019cites this paper
• Latest Advances in the Development of Eukaryotic Vaults as Targeted Drug Delivery Systems

  2019cites this paper
• Human Vault Nanoparticle Targeted Delivery of Antiretroviral Drugs to Inhibit Human Immunodeficiency Virus Type 1 Infection.

  2019cites this paper
• Protein cage assembly across multiple length scales.

  2018cites this paper
• Tailoring lumazine synthase assemblies for bionanotechnology.

  2018cites this paper
• Synthesis and assembly of human vault particles in yeast

  2018cites this paper
• Encapsulation of Exogenous Proteins in Vault Nanoparticles.

  2018cites this paper
• Bioengineering Strategies for Protein-Based Nanoparticles

  2018cites this paper
• Sequestered: Design and Construction of Synthetic Organelles

  2018cites this paper
• Nanotechnology for Synthetic Biology: Crossroads Throughout Spatial Confinement

  2017cites this paper
• Molecular Design of a Minimal Peptide Nanoparticle.

  2017cites this paper
• Bioengineering towards self-assembly of particulate vaccines.

  2017cites this paper
• Modulation of the Vault Protein-Protein Interaction for Tuning of Molecular Release

  2017cites this paper
• A Protective Vaccine against Chlamydia Genital Infection Using Vault Nanoparticles without an Added Adjuvant

  2017cites this paper
• Vault Nanoparticles: Chemical Modifications for Imaging and Enhanced Delivery.

  2017cites this paper
• Bioaugmentation with Vaults: Novel In Situ Remediation Strategy for Transformation of Perfluoroalkyl Compounds

  2016cites this paper
• The potential of protein-based nanocages for imaging and drug delivery

  2016cites this paper
• Vaccine technologies: From whole organisms to rationally designed protein assemblies

  2016influential citation
• The potential of protein-based nanocages for imaging and drug delivery.

  2016cites this paper
• Protein cages and synthetic polymers: a fruitful symbiosis for drug delivery applications, bionanotechnology and materials science.

  2016cites this paper
• Decrease in pH destabilizes individual vault nanocages by weakening the inter-protein lateral interaction

  2016cites this paper
• Bioengineered protein-based nanocage for drug delivery.

  2016cites this paper
• Porous carbon@MnO2 and nitrogen-doped porous carbon from carbonized loofah sponge for asymmetric supercapacitor with high energy and power density

  2016cites this paper
• Design and optimization of peptide nanoparticles

  2015cites this paper
• Peroxidase Enzymes Packaged in Vaults as an Innovative Bioremediation Technology

  2015cites this paper
• Dual pH- and Temperature-Responsive Protein Nanoparticles.

  2015cites this paper
• Intracellular targeting of CD 44 + cells with 3 self-assembling , protein only nanoparticles 4

  2015cites this paper
• Nanotechnology to augment immunotherapy for the treatment of glioblastoma multiforme

  2015cites this paper
• Early stage P22 viral capsid self-assembly mediated by scaffolding protein: atom-resolved model and molecular dynamics simulation.

  2015cites this paper
• Absence of association between major vault protein (MVP) gene polymorphisms and drug resistance in Chinese Han patients with partial epilepsy.

  2015cites this paper
• The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors

  2015cites this paper
• Vault Nanoparticles Packaged with Enzymes as an Efficient Pollutant Biodegradation Technology.

  2015cites this paper
• Bioengineered Vaults: Self-Assembling Protein Shell–Lipophilic Core Nanoparticles for Drug Delivery

  2014cites this paper
• Structure of Dihydromethanopterin Reductase, a Cubic Protein Cage for Redox Transfer*

  2014cites this paper
• Recent advancements in optofluidics-based single-cell analysis: optical on-chip cellular manipulation, treatment, and property detection.

  2014cites this paper
• The role of regulatory T-cells in glioma immunology.

  2014cites this paper
• Understanding enzymatic acceleration at nanoparticle interfaces: Approaches and challenges

  2014cites this paper
• Intracellular targeting of CD44+ cells with self-assembling, protein only nanoparticles.

  2014cites this paper
• Recombinant protein materials for bioengineering and nanomedicine.

  2014cites this paper
• Polyribosomes Are Molecular 3D Nanoprinters That Orchestrate the Assembly of Vault Particles

  2014cites this paper
• Mechanical stability and reversible fracture of vault particles.

  2014cites this paper
• Has nanomedicine lived up to its promise?

  2014cites this paper
• Genetically engineered nanocarriers for drug delivery

  2014cites this paper
• , Julien Transfer RedoxReductase , a Cubic Protein Cage for Structure of Dihydromethanopterin Protein Structure and Folding

  2014cites this paper
• In vivo architectonic stability of fully de novo designed protein-only nanoparticles.

  2014cites this paper
• Improved performance of protein‐based recombinant gene therapy vehicles by tuning downstream procedures

  2013cites this paper
• Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis

  2013cites this paper
• Vault-poly-ADP-ribose polymerase in the Octopus vulgaris brain: a regulatory factor of actin polymerization dynamic.

  2013cites this paper
• De novo design of self-assembling protein nanoparticles towards the gene therapy of colorectal cancer

  2013cites this paper